Similar to the seemingly contradictory roles of MTA1, the residual expression of elafin in invasive breast cancer predicts a significantly poor prognosis of breast cancer patients: a tumor suppressor gene turned into an oncogene [37]. The gene discussed is PI3; the disease is invasive breast carcinoma.